Literature DB >> 27484980

Long-Term Outcomes and Prognostic Factors in Periampullary Carcinoma.

Bhanu Jayanand Sunil1, Ramakrishnan A Seshadri2, S Gouthaman3, Rama Ranganathan4.   

Abstract

PURPOSE: The aim of the study was to analyze the long-term survival and the various prognostic factors that influence overall survival in patients undergoing pancreaticoduodenectomy (PD) with non-pancreatic periampullary carcinomas.
METHODS: A retrospective analysis of consecutive patients diagnosed with non-pancreatic periampullary carcinomas who underwent PD at a tertiary cancer center was performed. Univariate analysis of various prognostic factors influencing the disease-free survival (DFS) was performed using log-rank test. Factors identified to be significant in univariate analysis were included in the multivariate analysis, which was performed using the Cox proportional hazard model. The survival estimates were calculated by life-table method. Statistical significance was considered when p value was <0.05. The SPSS v16.0.1 software was used for statistical analysis.
RESULTS: Between 1995 and 2010, 78 patients underwent PD with or without (Whipple's operation) pylorus preservation for non-pancreatic periampullary adenocarcinomas. Of these, eight patients received adjuvant chemotherapy. The most common subsite was ampulla (60 patients), followed by the second part duodenum (11 patients), and distal common bile duct (7 patients). The median duration of follow-up of all patients in this study was 50 months. The recurrence rate was 39.7 %. The 5-year disease-free survival and overall survival was 57 %. Patients without nodal metastasis had a non-significant trend towards better 5-year disease-free survival when compared to those with nodal metastasis (64 vs 45 %, p = 0.11). On multivariate analysis, it was found that male gender (p = 0.05) and presence of lymphovascular invasion (p = 0.04) predicted a significantly poor 5-year disease-free survival.
CONCLUSION: Periampullary carcinomas have a favorable prognosis after surgery. Male gender and presence of lymphovascular invasion are independent prognostic factors in patients diagnosed with non-pancreatic periampullary carcinomas who underwent PD in this study.

Entities:  

Keywords:  Lymphovascular invasion; Pancreaticoduodenectomy; Periampullary carcinoma; Prognostic factors; Survival

Mesh:

Year:  2017        PMID: 27484980     DOI: 10.1007/s12029-016-9863-z

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  28 in total

1.  Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.

Authors:  J H Klinkenbijl; J Jeekel; T Sahmoud; R van Pel; M L Couvreur; C H Veenhof; J P Arnaud; D G Gonzalez; L T de Wit; A Hennipman; J Wils
Journal:  Ann Surg       Date:  1999-12       Impact factor: 12.969

2.  The management of tumors of the ampulla of Vater by local resection.

Authors:  G D Branum; T N Pappas; W C Meyers
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

3.  Presentation, treatment and outcome in patients with ampullary tumours.

Authors:  V Bettschart; M Q Rahman; F J F Engelken; K K Madhavan; R W Parks; O J Garden
Journal:  Br J Surg       Date:  2004-12       Impact factor: 6.939

4.  Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.

Authors:  Tadahiro Takada; Hodaka Amano; Hideki Yasuda; Yuji Nimura; Takashi Matsushiro; Hiroyuki Kato; Takukazu Nagakawa; Toshimichi Nakayama
Journal:  Cancer       Date:  2002-10-15       Impact factor: 6.860

5.  Long-term results of surgical treatment of Vater's ampulla neoplasms.

Authors:  Pascal Bucher; Gilles Chassot; Ymer Durmishi; Frederic Ris; Philippe Morel
Journal:  Hepatogastroenterology       Date:  2007-06

6.  Periampullary adenocarcinoma: analysis of 5-year survivors.

Authors:  C J Yeo; T A Sohn; J L Cameron; R H Hruban; K D Lillemoe; H A Pitt
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

7.  Assessment of survival advantage in ampullary carcinoma in relation to tumour biology and morphology.

Authors:  G Morris-Stiff; E Alabraba; Y-M Tan; I Shapey; C Bhati; P Tanniere; D Mayer; J Buckels; S Bramhall; D F Mirza
Journal:  Eur J Surg Oncol       Date:  2009-01-23       Impact factor: 4.424

8.  Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.

Authors:  Charles J Yeo; John L Cameron; Keith D Lillemoe; Taylor A Sohn; Kurtis A Campbell; Patricia K Sauter; JoAnn Coleman; Ross A Abrams; Ralph H Hruban
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

9.  Predictors of survival in periampullary cancers following pancreaticoduodenectomy.

Authors:  Ioannis Hatzaras; Nathaniel George; Peter Muscarella; W Scott Melvin; E Christopher Ellison; Mark Bloomston
Journal:  Ann Surg Oncol       Date:  2010-01-28       Impact factor: 5.344

10.  Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment.

Authors:  Satoshi Kondo; Tadahiro Takada; Masaru Miyazaki; Shuichi Miyakawa; Kazuhiro Tsukada; Masato Nagino; Junji Furuse; Hiroya Saito; Toshio Tsuyuguchi; Masakazu Yamamoto; Masato Kayahara; Fumio Kimura; Hideyuki Yoshitomi; Satoshi Nozawa; Masahiro Yoshida; Keita Wada; Satoshi Hirano; Hodaka Amano; Fumihiko Miura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-02-16
View more
  2 in total

1.  Brain metastasis and herniation in a patient with ampullary adenocarcinoma presenting with jaundice and memory loss: case report.

Authors:  Abdullah Saleh ALQattan; Omar Ali Al-Ghamdi; Mumtaz Sarang; Mohammed Saad Al-Qahtani
Journal:  J Gastrointest Oncol       Date:  2018-10

2.  Influence of non-jaundice stage at diagnosis on clinicopathological features and long-term survival of patients with periampullary carcinomas.

Authors:  Xiaoqian Peng; Xiaoxiao Jiao; Ping Zhao; Rongtao Zhu; Yuling Sun; Lin Zhou
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.